SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Painter Tyler

(Last) (First) (Middle)
SOLAZYME, INC.
225 GATEWAY BOULEVARD

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/26/2011
3. Issuer Name and Ticker or Trading Symbol
SOLAZYME INC [ SZYM ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 383,986(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series C Preferred Stock (2) (3) Common Stock 2,250(4) $0 D
Stock Option (right to buy) (5) 09/16/2018 Common Stock 25,000 $0.86 D
Stock Option (right to buy) (6) 06/08/2019 Common Stock 100,000 $0.86 D
Stock Option (right to buy) (7) 06/13/2020 Common Stock 55,000 $2.35 D
Stock Option (right to buy) (8) 10/06/2020 Common Stock 100,000 $2.35 D
Stock Option (right to buy) (9) 12/15/2020 Common Stock 50,000 $6.79 D
Stock Option (right to buy) (10) 03/08/2021 Common Stock 50,000 $8.77 D
Explanation of Responses:
1. A portion of these shares is subject to a right of repurchase held by the Issuer.
2. The securities are immediately convertible.
3. The expiration date is not relevant to the conversion of these securities.
4. Each share of preferred stock will automatically convert on a 1-for-1 basis into common stock upon the closing of the Issuer's initial public offering.
5. All shares are immediately exercisable. The original option grant vests at a rate of 1/48 per month, beginning September 17, 2008.
6. All shares are immediately exercisable. The original option grant vests at a rate of 1/48 per month, beginning January 1, 2009.
7. All shares are immediately exercisable. The original option grant vests at a rate of 1/48 per month, beginning January 1, 2010.
8. All shares are immediately exercisable. The original option grant vests at a rate of 1/48 per month, beginning September 16, 2010.
9. All shares are immediately exercisable. The original option grant vests at a rate of 1/48 per month, beginning December 16, 2010.
10. All shares are immediately exercisable. The original option grant vests at a rate of 1/48 per month, beginning March 9, 2011.
Remarks:
/s/ Tyler W. Painter 05/26/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.